Literature DB >> 22493345

Stem cell markers as predictors of oral cancer invasion.

Amanda Siu1, Carlin Lee, Dongmin Dang, Casey Lee, Daniel M Ramos.   

Abstract

We previously showed that within primary tumors there exist subpopulations of cells expressing stem cell markers. Using immunofluorescence and western blotting, we examined the expression of stem cell markers tumor-rejection antigen 1-60 (TRA1-60) and octamer-binding transcription factor 3/ 4 (OCT3/4) to determine their relationship with cell invasiveness. Six human oral cancer cell lines were examined and a direct correlation was found between expression of these stem cell markers and invasion. Poor expression of E-cadherin and increased expression of N-cadherin was also found in TRA1-60- and OCT3/4- expressing cells. Phosphorylation of the major signaling molecule mitogen activated protein kinase (MAPK) was greatest in the TRA1-60- and OCT3/4- expressing cells. These results suggest that expression of specific stem cell markers in tumors may help guide a clinician's choice of treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493345

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.

Authors:  Elisabeth I Heath; Lance K Heilbrun; Daryn Smith; William M Schopperle; Yawen Ju; Susan Bolton; Quratulain Ahmed; Wael A Sakr
Journal:  Anticancer Res       Date:  2018-11       Impact factor: 2.480

2.  Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.

Authors:  Yin-Ju Chen; Chia-Chun Kuo; Lai-Lei Ting; Long-Sheng Lu; Ya-Ching Lu; Ann-Joy Cheng; Yun-Tien Lin; Chien-Ho Chen; Jo-Ting Tsai; Jeng-Fong Chiou
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

Review 3.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

4.  Oncogenic effects of miR-10b in glioblastoma stem cells.

Authors:  Fadila Guessous; Melissa Alvarado-Velez; Lukasz Marcinkiewicz; Ying Zhang; Jungeun Kim; Simon Heister; Benjamin Kefas; Jakub Godlewski; David Schiff; Benjamin Purow; Roger Abounader
Journal:  J Neurooncol       Date:  2013-01-10       Impact factor: 4.130

5.  A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.

Authors:  R Masood; C Hochstim; B Cervenka; S Zu; S K Baniwal; V Patel; A Kobielak; U K Sinha
Journal:  Oncogenesis       Date:  2013-09-09       Impact factor: 7.485

6.  Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells.

Authors:  Liliana P Cantini; Lourdes M Andino; Christopher C Attaway; Betsy Butler; Anca Dumitriu; Aaron Blackshaw; Andrew Jakymiw
Journal:  Mol Cancer       Date:  2014-08-13       Impact factor: 27.401

7.  Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts.

Authors:  Yuyang Li; Zhiming Xu; Jia Li; Shuofeng Ban; Congcong Duan; Weiwei Liu
Journal:  FEBS Open Bio       Date:  2018-10-31       Impact factor: 2.693

8.  Cancer stem cell markers in head and neck squamous cell carcinoma.

Authors:  Aidan G Major; Luke P Pitty; Camile S Farah
Journal:  Stem Cells Int       Date:  2013-03-03       Impact factor: 5.443

9.  Correlation of CD133 and Oct-4 expression with clinicopathological and demographic parameters in oral squamous cell carcinoma patients.

Authors:  Alok Singh; Anand Narain Srivastava; Salman Akhtar; Mohammad Haris Siddiqui; Pooja Singh; Vijay Kumar
Journal:  Natl J Maxillofac Surg       Date:  2018 Jan-Jun

10.  Characterisation of a subpopulation of CD133+ cancer stem cells from Chinese patients with oral squamous cell carcinoma.

Authors:  Zhen Ma; Chong Zhang; Xiaotong Liu; Fang Fang; Shiqi Liu; Xianxiang Liao; Shicheng Tao; Huaming Mai
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.